Breath markers of oxidative stress in patients with unstable angina

Heart Disease

Volumn 5, Issue 2, 2003, Pages 95-99

  Phillips, Michael ^a,b   Cataneo, Renee N ^a   Greenberg, Joel ^a   Grodman, Richard ^c   Salazar, Manuel ^c,d  

^a MENSSANA RESEARCH INC   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c ST VINCENT S HOSPITAL   (United States)

^d NONE   (United States)

Author keywords

Ischemic heart disease; Oxidative stress; Oxygen free radicals; Volatile organic compounds

Indexed keywords

BUTANE; DECANE; HEXADECANE; HEXANE; OCTANE; PENTANE; PROPANE; VOLATILE ORGANIC COMPOUND;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE MARKER; HUMAN; OXIDATIVE STRESS; SENSITIVITY AND SPECIFICITY; UNSTABLE ANGINA PECTORIS;

ALKANES; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; BREATH TESTS; CASE-CONTROL STUDIES; DISCRIMINANT ANALYSIS; HUMANS; METHYLATION; METHYLTRANSFERASES; MIDDLE AGED; MODELS, STATISTICAL; OXIDATIVE STRESS; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; REACTIVE OXYGEN SPECIES; SENSITIVITY AND SPECIFICITY;

EID: 0038713347     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hdx.0000061701.99611.e8     Document Type: Article

References (37)

1. Dhalla NS, Golfman L, Takeda S, et al. Evidence for the role of oxidative stress in acute ischemic heart disease: a brief review. Can J Cardiol. 1999;15:587-593.
2. Chandra M, Chandra N, Agrawal R, et al. The free radical system in ischemic heart disease. Int J Cardiol. 1994;43:121-125.
3. Kneepkens CM, Ferreira C, Lepage G, et al. The hydrocarbon breath test in the study of lipid peroxidation: principles and practice. Clin Invest Med. 1992;15:163-186.
4. Kneepkens CM, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med. 1994;17:127-160.
5. Weitz ZW, Birnbaum AJ, Sobotka PA, et al. High breath pentane concentrations during acute myocardial infarction. Lancet. 1991;337: 933-935.
6. Sobotka PA, Brottman MD, Weitz Z, et al. Elevated breath pentane in heart failure reduced by free radical scavenger. Free Radic Biol Med. 1993;14:643-647.
7. Kohlmuller D, Kochen W. Is n-pentane really an index of lipid peroxidation in humans and animals? A methodological reevaluation. Anal Biochem. 1993;210:268-276.
8. Humad S, Zarling E, Clapper M, et al. Breath pentane excretion as a marker of disease activity in rheumatoid arthritis. Free Radic Res Commun. 1988;5:101-106.
9. Olopade CO, Zakkar M, Swedler WI, et al. Exhaled pentane levels in acute asthma. Chest. 1997;111:862-865.
10. Phillips M, Sabas M, Greenberg J. Increased pentane and carbon disulfide in the breath of patients with schizophrenia. J Clin Pathol. 1993;46:861-864.
11. Gerster H. Function of vitamin E in physical exercise: a review. Z Ernahrungswiss. 1991;30:89-97.
12. Phillips M. Method for the collection and assay of volatile organic compounds in breath. Anal Biochem. 1997;247:272-278.
13. Phillips M, Herrera J, Krishnan S, et al. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl. 1999;729:75-88.
14. Phillips M, Cataneo RN, Greenberg J, et al. Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. J Lab Clin Med. 2000;136:243-249.
15. Phillips M, Boehmer J, Cataneo R, et al. Heart Allograft Rejection: Detection with Breath Alkanes in Low Levels (the HARDBALL study). J Am Coll Cardiol. 2002;1:12-13.
16. Phillips M, Cataneo R, Greenberg J, et al. Effects of oxygen on breath markers of oxidative stress. Eur Respir J. 2003;21:48-51.
17. Braunwald E. Unstable angina. A classification. Circulation. 1989;80: 410-414.
18. SPSS for Windows, standard version. Chicago: SPSS Science, 1998.
19. Efron B. The Jackknife, the Bootstrap, and Other Resampling Plans. CBMS-NSF Regional Conference Series in Applied Mathematics 38. Philadelphia: Society for Industrial and Applied Mathematics; 1982.
20. Fletcher R, Fletcher S, Wagner E. Clinical Epidemiology. The Essentials. Baltimore: Williams & Wilkins; 1996.
21. Andican G, Koldas L, Seven A, et al. Biochemical evaluation of oxidative stress during exercise in patients with coronary heart disease. Clin Chem Lab Med. 2001;39:234-238.
22. Kostner K, Hornykewycz S, Yang P, et al. Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls. Cardiovasc Res. 1997;36:330-336.
23. Morita Y, Takahashi H, Kamihata H, et al. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases after spasm provocation tests in patients with coronary spastic angina. Int J Cardiol. 2001;80:243-250.
24. Kaur G, Pandey NR, Chandra M, et al. Lipid peroxidation in human blood platelets during unstable angina and myocardial infarction. Boll Chim Farm. 2000;139:267-269.
25. Araki T, Kanaya H, Shimizu M, et al. Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty. J Cardiol. 2001;38:55-60,
26. Kishimoto C, Shioji K, Nakamura H, et al. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J. 2001;65:491-494.
27. Turgan N, Boydak B, Habif S, et al. Urinary hypoxanthine and xanthine levels in acute coronary syndromes. Int J Clin Lab Res. 1999;29:162-165.
28. Rigattieri S, Buffon A, Ramazzotti V, et al. Oxidative stress in ischemia-reperfusion injury: assessment by three independent biochemical markers. Ital Heart J. 2000;1:68-72.
29. Knight JA. Free radicals: their history and current status in aging and disease. Ann Clin Lab Sci. 1998;28:331-346.
30. Favier A. Oxidative stress: value of its demonstration in medical biology and problems posed by the choice of a marker. Ann Biol Clin (Paris). 1997;55:9-16.
31. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens. 2000;18:655-673.
32. Keith ME, Jeejeebhoy KN, Langer A, et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr. 2001;73:219-224.
33. Matsuda Y, Akita H, Terashima M, et al. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease. Am Heart J. 2000; 140:753-759.
34. Ghiselli A, D'Amicis A, Giacosa A. The antioxidant potential of the Mediterranean diet. Eur J Cancer Prev. 1997;6(Suppl 1):S15-9.
35. Cracowski JL, Stanke-Labesque F, Souvignet C, et al. Isoprostanes: new markers of oxidative stress in human diseases. Presse Med. 2000;29: 604-610.
36. Zarling EJ, Mobarhan S, Bowen P, et al. Pulmonary pentane excretion increases with age in healthy subjects. Mech Ageing Dev. 1993;67:141-147.
37. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284:835-842.